Combined use of coenzyme Q10 and citicoline: A new possibility for patients with glaucoma
Frontiers in Medicine, 2022 Glaucoma is the leading cause of irreversible blindness worldwide. Several risk factors have been involved in the pathogenesis of the disease. By now, the main treatable risk factor is elevated intraocular pressure.
Alessio Martucci +5 more
doaj +1 more source
New Therapeutic Targets for Intraocular Pressure Lowering
ISRN Ophthalmology, 2013 Primary open-angle glaucoma (POAG) is a leading cause of irreversible and preventable blindness and ocular hypertension is the strongest known risk factor. With current classes of drugs, management of the disease focuses on lowering intraocular pressure (IOP). Despite of their use to modify the course of the disease, none of the current medications for
Rocha-Sousa, A. +6 more
openaire +2 more sources
Topical prostaglandin analogues and conjunctival inflammation in uveitic glaucoma. [PDF]
, 2012 20.02.14 KB. Ok to add published verson to spiral, OA paper.A pilot study to determine whether topical prostaglandin analogues alter the expression of conjunctival inflammatory markers in patients with uveitic glaucoma.Prospective, single-masked case ...
Sallam, A +3 more
core +1 more source
The Outcomes of Bleb Revision Surgery Techniques After Trabeculectomy
Türk Oftalmoloji Dergisi, 2012 Pur po se: To evaluate the techniques and the results of revision surgeries in order to manage bleb failure after trabeculectomy. Ma te ri al and Met hod: The records of 23 eyes who had undergone bleb revision surgery because of bleb failure after ...
Orhan Ayar +5 more
doaj +1 more source
Therapeutic Advances in Ophthalmology, 2020 Background: Glaucoma is most common irreversible cause of blindness in India. First line management of open-angle glaucoma is either beta blockers or prostaglandin analogs monotherapy.
Alok Dixit, Atul Ashish, Reena Sharma
doaj +1 more source
Intravenous paracetamol and intraocular pressure reduction: Mannitol may also be involved [PDF]
, 2016 Karel Allegaert1,2 1Intensive Care, Department of Surgery, Erasmus MC Sophia Children’s Hospital, Rotterdam, the Netherlands; 2Department of Development and Regeneration, KU Leuven, BelgiumI read, with great interest, the paper on the ...
Allegaert, Karel +2 more
core +1 more source
Target IOP as a measure of glaucoma surgery efficacy
Oftalʹmologiâ, 2015 There are numerous criteria of glaucoma surgery efficacy. Among them, IOP level is of special importance. The development of tolerant and target IOP concepts as well as IOP tolerability issue are reviewed below.
S. Yu. Petrov
doaj +3 more sources
Long-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: a prospective, observational, noninterventional study [PDF]
, 2010 Background: Prospective, observational studies that enroll large numbers of patients with few exclusion criteria may better reflect actual ongoing clinical experience than randomized clinical trials.
Guzy, Claudia +11 more
core +2 more sources
From Bench to Bed: The Current Genome Editing Therapies for Glaucoma
Frontiers in Cell and Developmental Biology, 2022 Glaucoma is a group of optic neuropathies featured by degeneration of retinal ganglion cells and loss of their axons in the optic nerve. The only currently approved therapies focus on lowering intraocular pressure with medication and surgery.
Meihui He +11 more
doaj +1 more source
Surgery for normal tension glaucoma. Target intraocular pressure and visual field progression [PDF]
Acta Ophthalmologica Scandinavica, 1997 No abstract ...
Fontana L +4 more
openaire +3 more sources